Enrichment Strategies for Identification and Characterization of Phosphoproteome
Enrichment Strategies for Identification and Characterization of Phosphoproteome
Mass Spectrometry Letters. 2015. Jun, 6(2): 31-37
Copyright © 2015, Korean Society Mass Spectrometry
All MS Letters content is Open Access, meaning it is accessible online to everyone, without fee and authors’ permission. All MS Letters content is published and distributed under the terms of the Creative Commons Attribution License ( Under this license, authors reserve the copyright for their content; however, they permit anyone to unrestrictedly use, distribute, and reproduce the content in any medium as far as the original authors and source are cited. For any reuse, redistribution, or reproduction of a work, users must clarify the license terms under which the work was produced.
  • Received : May 11, 2015
  • Accepted : June 17, 2015
  • Published : June 30, 2015
Export by style
Cited by
About the Authors
Sun Young, Lee
Center for Bioanalysis, Division of Metrology for Quality of Life, Korea Research Institute of Standards and Science, Daejeon, 305-340, Korea
Dukjin, Kang
Center for Bioanalysis, Division of Metrology for Quality of Life, Korea Research Institute of Standards and Science, Daejeon, 305-340, Korea,
Jongki, Hong
College of Pharmacy, Kyung Hee University, Seoul, 130-701, Korea,

Phosphorylation upon protein is well known to a key regulator that implicates in modulating many cellular processes like growth, migration, and differentiation. Up to date, grafting of multidimensional separation techniques onto advanced mass spectrometry (MS) has emerged as a promising tool for figuring out the biological functions of phosphorylation in a cell. However, advanced MS-based phosphoproteomics is still challenging, due to its intrinsic issues, i.e., low stoichiometry, less susceptibility in positive ion mode, and low abundance in biological sample. To overcome these bottlenecks, diverse techniques ( e.g ., SCX, HILIC, ERLIC, IMAC, TiO 2 , etc.) are continuously developed for on-/off-line enrichment of phosphorylated protein (or peptide) from biological samples, thereby helping qualitative/quantitative determination of phosphorylated protein and its phosphorylated sites. In this review, we introduce to the overall views of enrichment tools that are universally used to selectively isolate targeted phosphorylated protein (or peptide) from ordinary ones before MS-based phospoproteomic analysis.
Reversible protein phosphorylation occurring on serine, threonine and tyrosine in eukaryotes, one of post-translati-onal modifications (PTMs), plays a crucial role in regulation of the many cellular processes including signal transduction, differentiation, transcription and translation. 1 - 4 Aberrant phosphorylation in cell signaling pathway can lead to mutation, overexpression or abnormal operation of regular enzymes such as protein kinases and phosphatases. 5 , 6 Hence, the global profiling and quantification of phosphoproteins and their phosphorylated sites are of importance for understanding the biological pathway related with the key biological processes in a cell. 7 - 9
Liquid chromatography-mass spectrometry (LC-MS) have been reported for analyzing the phosphoproteins and their phosphorylation sites because of the high sensitivity, precision and accuracy. 10 , 11 Especially, tandem mass spectrometry (MS/MS) has served for information associated with the presence of phosphorylation events and their localization on phosphoproteins. However, the detection of phosphoproteins by MS might be difficult because phosphorylation of proteins is a transient modification, phosphoproteins within cells are relatively low stoichiometry in comparison to nonphosphorylated counterparts, and phosphate group causes by ionization suppression in MS analyses. 12 , 13 Thus, the fractionation and enrichment strategies prior to MS analysis are necessary for reducing the above mentioned challenges.
A variety of enrichment and fractionation methods in phosphoproteomics have been reported including the enrichment with immobilized metal affinity chromatography (IMAC) 6 , 14 - 16 and metal oxide affinity chromatography (MOAC) as well as titanium dioxide (TiO 2 ), 17 - 25 and fractionation with strong cation exchange (SCX), 26 , 27 hydrophilic interaction chromatography (HILIC), 28 - 30 and electrostatic repulsion-hydrophilic interaction chromatography (ERLIC). 31 - 33 More recently, the two sequential steps of preparation methods are commonly used in large scale phosphoproteomics. A fractionation step performs to reduce sample complexity, and followed by an enrichment for increasing the number of identified phosphopeptides and their phosphorylation sites, such as SCX-TiO 2 , 34 - 36 SCX-IMAC, 37 , 38 ERLIC-IMAC 39 and IMAC-TiO 2 . 40 , 41 Overall workflow of phosphoproteomic analysis using fractionation and enrichment are illustrated at Figure 1 .
PPT Slide
Lager Image
Systemic illustration for isolation of phosphopeptides from tryptic digests using fractionation and enrichment with LC-ESIMS/MS.
MS/MS-based experiments of phosphoprotein is accomplished with the fragmentation techniques, such as collision induced dissociation (CID), 42 - 44 electron capture dissociation (ECD), 45 and electron transfer dissociation (ETD). 46 Phosphoproteins consisting of phospho-serine and phospho-threonine residues in MS/MS analysis with CID are often produced the significant neutral loss of phosphate group, and these phenomenon affects to fragmentation for identification of phosphoproteins. On the other hand, phosphoprotein analysis by ECD or ETD prevents to cleave the unstable phosphate group, and offers the unambiguous information of phosphorylation site locations. 47
This article provides an overview of preparative and analytical strategies using LC-MS/MS for identification and characterization of phosphoproteins and their phosphorylation sites localizations. Furthermore, we reviewed on the fragmentation reactions of phosphoproteome by MS/MS in understanding biological network pathway.
Sample fractionations
- Strong cation exchange (SCX )
SCX chromatography is a universal fractionation technique for phosphoprotein (or phosphopeptide). 48 , 49 Proteins or peptides are retained on a column that contains a hydrophilic, anionic resin through the affinity to positively charged groups on amino acids ( Figure 2 -A). The main principle of SCX is the relationship between SCX matrix and oppositely charged proteins (or peptides) from biological sample according to their net surface charge and pI value. Because general peptides can change their charge depending on the pH of environment, phosphoproteins or phosphopeptides are weakly captured by the SCX column matrix, compare to general ones. All peptides will bind to a cation exchanger at low pH condition, and bound peptides are predominantly separated by a stepwise elution with increasing ionic strength and/or increasing pH value. 28 Through the above process, the peptides obtained from complex biological sample are divided to 6~12 fractions. Phosphoprotein (or phosphpeptides) bound to SCX matrix are eluted in the early fractions, and peptides except for phosphorylated counterparts are eluted gradually on high salt or pH conditions.
PPT Slide
Lager Image
Phosphopeptide fractionation strategies. Mono- and multi-phosphopeptides are separated from by (A) strong cation exchange (SCX), (B) hydrophilic interaction liquid chromatography (HILIC), and (C) electrostatic repulsion hydrophilic interaction chromatography (ERLIC) according to the concentration of salts, pH values of eluted solution, or percentage of organic solvent.
- Hydrophilic interaction chromatography (HILIC)
HILIC for separating the proteins and peptides rely on the partition of analytes between the used solvents and solid resins. 29 In HILIC, the hydrophilic peptides take to remain into chromatography column, the hydrophobic peptides eluted at early step in contrast with reverse phase chromatography. HILIC has been reported frequently in recent years in phosphoproteomic studies, because highly hydrophilic solutes as phosphorylated ones in comparison with common peptides are retained on the column for the longest time. 28 - 30 In HILIC, hydrophilic components acquired from biological specimens are typically bound onto HILIC column matrix when used with below 10 % aqueous. To isolate the phosphopeptides from ordinary ones, all peptides are fractionated by predominantly increasing the aqueous mobile phase up to 40% ( Figure 2 -B). Fractionations using HILIC facilitates the identification and characterization of phosphopeptides and number of phosphorylation sites, when combined with either IMAC or TiO 2 . Zappacosta and co-worker provided a collaboration of HILIC and IMAC for identification of more than 20,000 phosphopeptide from rat liver. 30 Most non-phosphopeptides from rat liver were removed in early steps (fraction 1~15), followed by the elution of mono and multiphosphopeptides by stepwise. Accordingly, HILIC is an alternative tool for phosphoprotein or phosphopeptide fractionation, and thus can be coupled online to MS analysis.
- Electrostatic repulsion-hydrophilic interaction liquid chromatography (ERLIC)
ERLIC chromatography, one of phosphopeptide fractionations, was first introduced by Alpert in 2008. 31 This technique is modified from HILIC approach and can be accomplished isocratically. 32 ERLIC matrix containing weak anion exchange and hydrophilic interactions allows for the isolation of phosphopeptides from other ones in proteolytic digests. Many phosphorylated proteins and peptides are more hydrophilic in comparison with their unmodified counterparts, can be separated with ERLIC ( Figure 2 -C). Separation of ERLIC is influences by pH, salt concentration, count-ion, a percent of organic solvent in mobile phase, etc. 32 , 33 ERLIC matrix prior to sample loading are acidified with a combination of organic acids with high percent of acetonitrile to remain the phosphopeptides from tryptic digests, and gradually fractionated by increasing concentration of salts. The eluted phosphopeptides using ERLIC protocol is recently applied in combination with reverse phase, TiO 2 , 50 SCX, 32 , 33 and IMAC. 39 Loroch, S. and co-worker demonstrated that HeLa cells digests were sequentially separated to 21 fractions using ERLIC combined with SCX, total 8998 phosphorylation sites from 3013 phosphoproteins are detected. 32 Early elutions (fraction 1-5) among 21 fractions are detected with mono-phosphopeptides, whereas the pooled middle fractions (fraction 10-15) are confirmed with multi-phosphopeptides.
Phosphopeptide enrichments
- Immobilized metal ion affinity chromatography (IMAC)
IMAC is a widely used technique to enrich phosphopeptides prior to MS analysis. Positively charged metal ions, such as Fe 3+ , 16 , 47 Zn 2+ , 15 Ga 3+ , 51 La 3+ , 52 and Ti 4+ , 38 , 47 are chelated to nitrilotriacetic acid (NTA) or iminodiacetic acid (IDA) resin and interacted with negatively charged phosphate groups ( Figure 3 A).One of the limitations in the IMAC technique is its partial non-specific binding of acidic peptides containing glutamic acid or aspartic acid residues when used for phosphopeptide enrichment, thereby introducing the inefficiency of IMAC. The pH values in IMAC specificity are an important factor, because the acid dissociation constant (pK a ) of phosphate group at serine/threonine (pKa 2.1) and tyrosin residues (pK a 1.0) is lower than other acidic amino acid including glutamic acid (pKa 3.65) and aspartic acid (pKa 4.25). 53 - 55 To minimize these issues, loading and binding buffers during phosphopeptide enrichment with IMAC were often used to pH 2-2.5 containing with organic acid [ e.g ., trifluoroacetic acid (TFA), acetic acid, hydrochloric acid and formic acid]. 50 A variety of organic acids have been used for high selectivity of IMAC, their influence resulted as follows: TFA > hydrochloric acid > formic acid > acetic acid. 53 On the contrary, the elution of phosphopeptides bound on IMAC was performed at strong basic conditions containing ammonium hydroxide, urea, or tris-buffer. Although IMAC is a friendly used approach for enrichment of phosphopeptides, further optimization of loading and eluting buffers requires as an essential part.
PPT Slide
Lager Image
Typical enrichment methods for phosphopeptides. (A) Immobilized metal ion affinity chromatography (IMAC) and (B) titanium dioxide (TiO2) able for the specific enrichment of phosphopeptides from ordinary peptides
- Titanium dioxide (TiO2)
The TiO 2 -based strategy, one of metal oxide affinity chromatography (MOAC), is the robustness, simplicity, and high efficiency for enrichment of phosphorylated proteins or peptides from complex biological sample ( Figure 3 B). TiO 2 techniques are usually performed using self-packed or commercial products with microcolumn, 17 , 56 or beads. 20 , 25 , 40 To improve the reproducibility of TiO 2 for phosphopeptide enrichment, Tape and co-worker described that the automatic phosphopeptide enrichment using magnetic TiO 2 beads with IMAC. 40 The automated enrichment system with magnetic TiO 2 beads is achieved by controlling 96-well plates at the eight carousel positions. Phosphopeptides from tryptic digests are more identified with magnetic beads and automatic system, compare to manual enrichment.
Selectivity of TiO 2 resin is influenced by the pH value of loading and eluting buffers similar to IMAC approach. To enhance the enrichment efficiency of TiO 2 resin, the loading buffer was acidified by organic acids ( e. g ., TFA, acetic acid, and formic acid). 57 , 58 However, acidification of buffers in phosphopeptide enrichment was not enough to diminish the binding of nonphosphopeptide. 59 In many reports, acidic loading buffers on TiO 2 have been tested and optimized with the modifiers including 2, 5-dihydroxybenzoic acid (DHB), malic acid, lactic acid, and other acidic reagents to enhance the enrichment efficiency of phosphopeptide. 17 - 21 Capacity of acidic modifier in loading buffer for removing non-specific binding decreased as follows: DHB = salicylic acid = phthalic acid > benzoic acid = cyclohexanecarboxylic acid > phosphoric acid > TFA > acetic acid. 53 In recently, specificity of TiO 2 chromatography was optimized by adding glycerol 60 or citric acid. 61 On the other hand, the phosphopeptides bound onto TiO 2 resins was released by diverse amines and salts ( e. g ., ammonium bicarbonate, ammonium hydroxide, and pyrrolidine). Due to many singly and multiply charged phosphopeptides exist in biological sample, the release of phosphorylated ones carried out by stepwise elution with two elution buffers having the different pH values. The first elution was performed by weakly basic conditions, subsequently eluted by adding strongly basic buffers.
In addition, on-line TiO 2 -based approach reported for the reproducibility, use-to-easy, and high-throughput in phosphoproteomics, unlike the abovementioned off-line approaches. 55 , 62 , 63 Pinkse and co-worker demonstrated that online phosphopeptide enrichment with TiO 2 resin is automatically carried out using ‘sandwich precolumns’ made up of reverse phase (RP)-TiO 2 -RP materials. 55 All peptides obtained from tryptic digests are remained in first RP precolumn at 3 µL/min. During an initial H 2 O/ACN gradient at low flow rate (~100 nL/min), non-phosphopeptides and phosphopeptides are transferred to analytical column and TiO 2 precolumn. The phosphopeptides binding on TiO 2 resins are released by injecting the elution buffer at high pH value and concentration of salts in a second H 2 O/ ACN gradient. Briefly, pH value of buffer solution, concentration of salts, and flow rate are the crucial parameters for phosphopeptide enrichment using online RP-TiO 2 -RP system. The above processes on TiO 2 protocol are beneficial for increasing the probability of phosphopeptide identification.
- Phosphopeptide entichment using β-elimination reaction
Affinity purification in cooperation with β-elimination of phosphopeptides is helpful for isolating phosphopeptide by modifying phosphate groups. 64 - 66 McLachlin and co-worker introduced the improved chemical modificationbased phosphopeptide enrichment strategy. 65 β-Elimination of phosphopeptide can be achieved with the solution made up of 25 mM N -hydroxysuccinmide and 0.5 M N,N -dimethylaminopropyl ethyl carbodiimide HCl, after condensation reaction using t -butyl-dicarbonate (tBoc). Then the resulting solutions are reacted utilizing ethanedithiol for improving the affinity with solid resins. Addition of EDTA during β-elimination reaction reduces the side effects. The treated phosphopeptides are reacted with the activated thiol affinity resins for isolating phosphopeptides from ordinary ones. Phosphopeptides enriched through affinity purification are separated from solid phase with TFA. The chemical modification-based affinity purification is the useful tool for enriching phosphopeptides from sample complex, and offers unambiguous information for phosphorylation site location.
- Combination with fractionation and enrichment
In phosphoproteomics, the two sequential steps with fractionation and enrichment methods are, in some cases, used to more identify phosphopeptides and their phosphorylation sites up to date. As shown in Table 1 , the starting materials of biological samples for phosphopeptide enrichment are used at approximately 0.1~3 mg, and the maximum amount is 15 mg of cell lysates. Most combinational strategies achieve utilizing two preparation methods, and present the synergy effect for identifying phosphopeptides and their phosphorylated sites than each approach. Zhou and co-worker introduced 3D-cooperative strategies with SCX, Ti 4+ -IMAC and HILIC. 28 Tryptic digests are fractionated via SCX collecting 22 fractions, and followed by desalting with C18 cartridge. Then, the eluted peptides are reconstituted with Ti 4+ -IMAC loading buffer after (80% ACN/6% TFA) dried under vacuum condition. The Ti 4+ -IMAC Gel-loader tips were packed with a C8 plug and Ti 4+ -IMAC beads. The prepared samples are applied to the Ti 4+ -IMAC tip conditioned with loading buffer. Subsequently, the retained phosphopeptides in Ti 4+ -IMAC beads are eluted by adding the elution buffer, and resulting phosphopeptides are additionally isolated by HILIC fractionation. The 3D strategies are remarkable for isolating the phosphopeptides from general counterparts, and identified 20788 and 28993 phosphopeptides for HeLa cells and K562 cells, respectively. Consequentially, the appropriate combination of pretreatments can help to acquire the significant information of phosphorylated peptides and its localizations related cell signaling pathways such as the protein ubiquitination pathway and the ERK/MAPK signaling pathway.
The recent trends of fractionation and enrichment in phosphoproteomics
PPT Slide
Lager Image
The recent trends of fractionation and enrichment in phosphoproteomics
- Mass spectrometry analysis of phosphopeptides
Phosphopeptides enriched from tryptic digests are introduced into MS via electrospray ionization (ESI) or matrix assisted laser desorption ionization (MALDI), and precursor ions of phosphopeptides is sequenced by MS/MS analysis. 47 , 62 The MS/MS techniques extensively used in phosphoproteomics are CID, ECD, and ETD. 45 , 46 , 67 In CID-MS/MS experiments, the peptide is slowly generated the precursor ion and fragment through lowest energy pathway, it is cleaved the peptide bond from N-terminus (b-type ions) or C-terminus (y-type ions). 45 Peptides having phosphoserine or phosphothreonine residues usually produce to both phosphopeptide backbone fragments and neutral loss of phosphoric acid (H 3 PO 4 ) during CID fragmentation. Although neutral loss of H 3 PO 4 indicates a presence of phosphorylation in peptide sequence, it prevents for identification and quantification of phosphopeptide and their phosphorylated locations with accuracy. 43 , 44 While ECD is trapped a low energy electron by a multiply charged precursor cation, 45 and ETD is transferred electrons from anion to a multiply charged precursor cation. 47 Both lead to dissociate the peptide bond, resulting in the production of c- and z-type ions. The fragmentation by ECD or ETD is adequate for phosphoproteome analysis because of the wide cleavage of peptide backbone without labile PTM as phosphorylation. 68 Sweet and co-worker demonstrated the availability of neutral loss triggered ECD for identifying and charactering phosphopeptides from β-casein as phosphoprotein standard. 45 The mass spectrum of β-casein phosphopeptides obtained from first MS scan event exhibit FQpSEEQQQTEDELQDK ( m/z 1031.4) corresponding to the doubly protonated ion ( Figure 4 A). The detected phosphopeptide ion is consequently introduced into CID MS/MS, and measured at m/z 982.4 with a neutral loss of 98 Da (H 3 PO 4 ) ( Figure 4 B). Finally, precursor ion ( m/z 1031.4) is analyzed with ECD MS/MS. Both precursor ion and charged-reduced species [M+2H] +• are observed at 1031.4 and 2062.8684, respectively ( Figure 4 C). Consequentially, the dissociation methods described above can offer the complementary information that the existence of phosphorylation in peptide, identification and quantification of phosphopeptides, and specific phosphorylation site locations.
PPT Slide
Lager Image
MS scan and tandem mass spectra of FQpSEEQQQTEDELQDK (+2, m/z 1031.4181) obtained from β-casein. (A) A full FT-MS scan (retention time 23.7 min.), (B) CID MS/MS scan of m/z 1031.4 analyzed using the linear ion trap, and (C) ECD MS/MS scan of m/z 1031.4. The reference reproduced from Sweet et al. (2006).62
We have introduced the overview of diverse fractionation and enrichment strategies for isolation of phosphoproteins and phosphopeptides from complex cellular components.
The cited phosphopeptide fractionating and enriching protocols are respectively relied on ion strength and chelating reaction between their matrix and phosphopeptides, and contributing to discovery of low abundant phosphopeptide functions and early diagnosis of diverse diseases. Additionally, the combination of phosphopeptide enrichment with sample fractionation prior to MS analysis is of key importance to overcome the existing challenges and to enable the identification of more phosphopeptides and phosphorylation site localizations.
The entire above-mentioned fractionation and enrichment approaches are well appropriated in phosphoproteomics, and two or more parallel strategies can be got the new information for understanding the function of phosphorylations in cellular network, and thus can help to identify novel phosphoproteins (or phosphopeptides) involved in therapeutic mechanisms from diseases.
Qian W. -J. , Goshe M. B. , Camp II D. G. , Yu L. -R. , Tang K. , Smith R. D. 2003 Anal. Chem. 75 105 -
Yan Y. , Sun X. , Deng C. , Li Y. , Zhang X. 2014 Anal. Chem. 86 4327 -    DOI : 10.1021/ac500047p
Atakay M. , Çelikbiçak Ö. , Salih B. 2012 Anal. Chem. 84 2713 -    DOI : 10.1021/ac203008u
Tan Y. -J. , Sui D. , Wang W. -H. , Kuo M. -H. , Reid G.E. , Bruening M. L. 2013 Anal. Chem. 85 5699 -    DOI : 10.1021/ac400198n
Marmelstein A.M. , Yates L. M. , Conway J. H. , Fiefler D. 2014 J. Am. Chem. Soc. 136 108 -    DOI : 10.1021/ja411737c
Tsai C. -F. , Wang Y. -T. , Chen Y. -R. , Lai C. -Y. , Lin P.-Y. , Pan K. -T. , Chen J. -Y. , Choo K. -H. , Chen Y. -J. 2008 J. Proteome Res. 7 4058 -    DOI : 10.1021/pr800364d
Imamura H. , Sugiyama M. , Wakabayashi M. , Ishihama Y. 2013 J. Proteome Res. 13 3410 -    DOI : 10.1021/pr500319y
Boehm M. E. , Adlung L. , Schilling M. , Roth S. , Klingmüller U. 2014 J. Proteome Res. 13 5685 -    DOI : 10.1021/pr5006923
Glibert P. , Meert P. , Steendam V. , Nieuwerburgh F. V. , Coninck D. D. , Martens L. , Dheanens M. , Deforce D. 2015 J. Proteome Res. 14 839 -    DOI : 10.1021/pr500889v
Qin W. , Zhang W. , Song L. , Zhang Y. , Qian X. 2010 Anal. Chem. 82 9461 -    DOI : 10.1021/ac1021437
Lu Z. , Duan J. , He L. , Hu Y. , Yin Y. 2010 Anal. Chem. 82 7249 -    DOI : 10.1021/ac1011206
Kweon H. K. , Håkansson K. 2006 Anal. Chem. 78 1743 -    DOI : 10.1021/ac0522355
Wang X. , Stewart P. A. , Cao Q. , Sna Q. –X. A. , Chung L. W. K. , Emmett M. R. , Marshall A. G. 2011 J. Proteome Res. 10 3920 -    DOI : 10.1021/pr2000144
Mertins P. , Udeshi N. D. , Clauser K. R. , Mani D. , Pater J. , Ong S. , Jaffe J. D. , Carr S. A. 2012 Mol. Cell. Proteomics 11 M111.014423-1 -    DOI : 10.1074/mcp.M111.014423
Lee J. O. , Kim E. -J. , Lim B. , Kim T. –W. , Kim Y. –P. 2015 Anal. Chem. 87 1257 -    DOI : 10.1021/ac5039412
Yue X. -S. , Hummon A. B. 2013 J. Proteome Res. 12 4176 -    DOI : 10.1021/pr4005234
Wang M. -C. , Lee Y. -H. , Liao P. -C. 2015 Anal. Bioanal. Chem. 407 1343 -    DOI : 10.1007/s00216-014-8352-0
Leitner A. , Sturm M. , Hudecz O. , Mazanek M. , Smått J. -H. , Lindén M. , Lindner W. , Mechtler K. 2010 Anal. Chem. 82 2726 -    DOI : 10.1021/ac902560z
Wang S. -T. , Wang M. -Y. , Su X. , Yuan B. -F. , Feng Y.-Q. 2012 Anal. Chem. 84 7763 -    DOI : 10.1021/ac301258q
Madden J. M. , Mueller K. L. , Bolling-Fischer A. , Stemmer P. , Mattingly R. R. , Boerner J. L. 2014 Breast Cancer Res. Treat 147 283 -    DOI : 10.1007/s10549-014-3102-8
Ye X. , Li L. 2014 Electrophoresis 35 3479 -    DOI : 10.1002/elps.201300586
Wiheratne A. B. , Manning J. R. , Schultz J. E. J. , Greis K. D. 2013 J. Proteome Res. 12 4268 -    DOI : 10.1021/pr400835k
Kwon O. K. , Sim J. , Yun K. N. , Kim J. Y. , Lee S. 2014 J. Proteome Res. 13 1327 -    DOI : 10.1021/pr400911x
Chen Z. , Yang M. , Li C. , Wang Y. , Zhang J. , Wang D. , Zhang X. , Ge F. 2014 J. Proteome Res. 13 2511 -    DOI : 10.1021/pr401290u
Tan H. , Wu Z. , Wang H. , Bai B. , Li Y. , Wang X. , Zhai B. , Beach T. G. , Peng J. 2015 Proteomics 15 500 -    DOI : 10.1002/pmic.201400171
Batth T. S. , Francavilla C. , Olsen J. V. 2014 J. Proteome Res. 13 6176 -    DOI : 10.1021/pr500893m
Lee J. H. , Hung S. -W. , Mun D. -G. , Jung H. -J. , Kim H. , Lee H. , Kim S. -J. , Park K. S. , Moore R. J. , Smith R. D. , Lee S. -W. 2012 J. Proteome Res. 11 4373 -    DOI : 10.1021/pr3004166
Zhou H. , Palma S. D. , Preisinger C. , Peng M. , Polat A. N. , Heck A. J. R. , Mohammed S. 2013 J. Proteome Res. 12 260 -    DOI : 10.1021/pr300630k
Engholm-Keller K. , Hansen T. A. , Palmisano G. , Larsen M. R. 2011 J. Proteome Res. 10 5383 -    DOI : 10.1021/pr200641x
Zappacosta F. , Scott G. F. , Huddleston M. J. , Annan R.S. 2015 J. Proteome Res. 14 997 -    DOI : 10.1021/pr501025e
Alpert A. J. 2008 Anal. Chem. 80 62 -    DOI : 10.1021/ac070997p
Loroch S. , Zahedi R. P. , Sickmann A. 2015 Anal. Chem. 87 1596 -    DOI : 10.1021/ac502708m
Hao P. , Qian J. , Ren Y. , Sze S. L. 2011 J. Proteome Res. 10 5568 -    DOI : 10.1021/pr2007686
Kettenbach A. N. , Gerber S. A. 2011 Anal. Chem. 83 7635 -    DOI : 10.1021/ac201894j
Matic K. , Eninger T. , Bardoni B. , Davidovic L. , Macek B. 2014 J. Proteome Res. 13 4388 -    DOI : 10.1021/pr5006372
Misra S. K. , Aké F. M. D. , Wu Z. , Milohanic E. , Cao T.N. , Cossart P. , Deutscher J. , Monnet V. , Archambaud C. , Henry C. 2014 J. Proteome Res. 13 6046 -    DOI : 10.1021/pr500929u
Oppermann F. S. , Klammer M. , Bobe C. , Cox J. , Schaab C. , Tebbe A. , Daub H. 2013 J. Proteome Res. 12 4089 -    DOI : 10.1021/pr400417g
Huang J. , Qin H. , Dong J. , Song C. , Bian Y. , Dong M. , Cheng K. , Wang F. , Sun D. , Wang L. , Ye M. , Zou H. 2014 J. Proteome Res. 13 3896 -    DOI : 10.1021/pr500454g
Chien K. , Lium H. -C. , Goshe M. B. 2011 J. Proteome Res. 10 4041 -    DOI : 10.1021/pr2002403
Tape C. J. , Worboys J. D. , Sinclair J. , Gourlay R. , Vogt J. , McMahon K. M. , Trost M. , Lauffernburger D. A. , Lamont D. J. , Jørgensen C. 2014 Anal. Chem. 86 10296 -    DOI : 10.1021/ac5025842
Matheron L. , Toorn H. , Heck A. J. R. , Mohammed S. 2014 Anal. Chem. 86 8312 -    DOI : 10.1021/ac501803z
Matheron L. , Sachon E. , Burlina F. , Sagan S. , Lequin O. , Bolbach G. 2011 Anal. Chem. 83 3003 -    DOI : 10.1021/ac103134e
Lassowskat I. , Naumann K. , Lee J. , Scheel D. 2013 Proteomics 1 254 -
Wang L. , Pan L. , Tao W. A. 2014 Anal. Chem. 86 6741 -    DOI : 10.1021/ac501641u
Sweet S. M. M. , Creese A. J. , Cooper H. J. 2006 Anal. Chem. 78 7563 -    DOI : 10.1021/ac061331i
Hansen T. A. , Sylvester M. , Jensen O. N. , Kjeldsen F. 2012 Anal. Chem. 84 9694 -    DOI : 10.1021/ac302364r
Lai A. C. -Y. , Tsai C. -F. , Hsu C. -C. , Sun Y. -N. , Chen Y. -J. 2012 Rapid Commun. Mass Spectrom. 26 2186 -    DOI : 10.1002/rcm.6327
Hennrich M. L. , Groenewold V. , Kops G. J. P. L. , Heck A. J. R. , Mohammed S. 2011 Anal. Chem. 83 7137 -    DOI : 10.1021/ac2015068
Beausoleil S. A. , Villén J. , Gerber S. A. , Rush J. , Gygi S. P. 2006 Nat. Biotechnol. 24 1285 -    DOI : 10.1038/nbt1240
Zarei M. , Sprenger A. , Metzger F. , Gretzmeier C. , Dengjel J. 2011 J. Proteome Res. 10 3474 -    DOI : 10.1021/pr200092z
Tsai C. -F. , Hsu C. -C. , Hung J. -N. , Wang Y. -T. , Choong W. -K. , Zeng M. -Y. , Lin P. -Y. , Hong R. -W. , Sung T. -Y. , Chen Y. -J. 2014 Anal. Chem. 86 685 -    DOI : 10.1021/ac4031175
Saeed A. , Haq M. N. , Jabeen F. , Svec F. 2013 Anal. Chem. 85 8979 -    DOI : 10.1021/ac4015484
Fíla J. , Hinys D. 2012 Amino Acids 43 1025 -    DOI : 10.1007/s00726-011-1111-z
Tang L. A. L. , Wang J. , Lim T. K. , Bi X. , Lee W. C. , Lin Q. , Chang Y. -T. , Lim C. T. , Loh K. P. 2012 Anal. Chem. 84 6693 -    DOI : 10.1021/ac301119r
Pinkes M. W. H. , Mohammed S. , Gouw J. W. , Breukelen B. , Vos H. R. , Heck A. J. R. 2008 J. Proteome Res. 7 687 -    DOI : 10.1021/pr700605z
Larsen M. R. , Thingholm T. E. , Jensen O. N. , Roepstorff P. , Jørgensen T. J. D. 2005 Mol. Cell. Proteomics 4 873 -    DOI : 10.1074/mcp.T500007-MCP200
Eriksson A. , Bergquist J. , Edwards K. , Hagfeldt A. , MalmstrÖm D. , Hernández V. A. 2011 Anal. Chem. 83 761 -    DOI : 10.1021/ac1027879
Erickson B. K. , Jedrychowski M. P. , McAlsster G. C. , Everley R. A. , Kunz R. , Gygi S. P. 2015 Anal. Chem. 87 1241 -    DOI : 10.1021/ac503934f
Nie S. , Dai J. , Ning Z. B. , Cao X. –J. , Sheng Q. –H. , Zeng R. 2010 J. Proteome Res. 9 4585 -    DOI : 10.1021/pr100632h
Fukuda I. , Hirabayashi-Ishioka Y. , Sakikawa I. , Ota T. , Yokoyama M. , Uchiumi T. , Morita A. 2013 J. Proteome Res. 12 5587 -    DOI : 10.1021/pr400546u
Zhao X. , Wang Q. , Wang S. , Zou X. , An M. , Zhang X. , Ji J. 2013 J. Proteome Res. 12 2467 -    DOI : 10.1021/pr301061q
Lemeer S. , Jopling C. , Gouw J. , Mohammed S. , Heck A. J. R. , Slijper M. , Hertog J. D. 2008 Mol. Cell. Proteomics 7 2176 -    DOI : 10.1074/mcp.M800081-MCP200
Raijmakers R. , Kraiczek K. , Jing A. P. , Mohammed S. , Heck A. J. R. 2010 Anal. Chem. 82 824 -    DOI : 10.1021/ac901764g
Zhou H. , Watts J. D. , Aebersold R. 2001 Nat. Biotechnol. 19 375 -    DOI : 10.1038/86777
McLachlin D. T , Chait B. T. 2003 Anal. Chem. 75 6826 -    DOI : 10.1021/ac034989u
Goshe M. B. , Conrads T. P. , Panisko E. A. , Angell N.H. , Veenstra T. D. , Smith R. D. 2001 Anal. Chem. 73 2578 -    DOI : 10.1021/ac010081x
Janek K. , Wenschuh H. , Bienert M. , Krause E. 2001 Rapid Commun. Mass Spectrom. 15 1593 -    DOI : 10.1002/rcm.417
Grimsrud P. A. , Swaney D. L. , Wenger C. D. , Beauchene N. A. , Coon J. J. 2010 ACS Chem. Biol. 5 105 -    DOI : 10.1021/cb900277e